Houston-based Bellicum Pharmaceuticals Inc. (Nasdaq: BLCM), a clinical-stage biopharmaceutical company focused on cellular immunotherapies, is selling a local facility to the University of Texas M.D. Anderson Cancer Center. M.D. Anderson will pay $15 million for the 60,000-square-foot facility, including manufacturing, office and laboratory space, according to a press release. Approximately 35 employees at the facility will transfer to M.D.

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News